Robert Gerardus Jules Marie Hanssen

Title: The Innovations of Robert Gerardus Jules Marie Hanssen

Introduction

Robert Gerardus Jules Marie Hanssen is a notable inventor based in BH Oss, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in fertility regulation. His work has led to the development of innovative compounds that activate specific receptors in the human body.

Latest Patents

Hanssen holds a patent for "Glycine-substituted thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity." This invention focuses on glycine-substituted thieno[2,3-d]pyrimidine derivatives, which possess both LH and FSH receptor activating activity. These compounds are particularly useful in fertility regulating therapies, offering new avenues for treatment.

Career Highlights

Hanssen is associated with N.V. Organon, a company known for its commitment to advancing healthcare through innovative solutions. His work at Organon has been instrumental in developing therapies that address fertility issues, showcasing his dedication to improving patient outcomes.

Collaborations

Hanssen has collaborated with notable colleagues, including Cornelis Marius Timmers and Jan Kelder. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Robert Gerardus Jules Marie Hanssen's contributions to the field of pharmaceuticals, particularly in fertility regulation, highlight his innovative spirit and commitment to advancing healthcare. His patent and work at N.V. Organon reflect the impact of his research on improving therapeutic options for patients.